Challenges and concerns of persistent opioid use in cancer patients

References

• Wiffen PJ, Wee B, Derry S, et al. Opioids for cancer pain - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;7:CD012592.
   PubMedGoogle Scholar
• Paice JA, Portenoy R, Lacchetti C, et al. Management of chronic pain in survivors of adult cancers: american Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016;34:3325–3345.
   PubMed Web of Science ®Google Scholar
• Posternak V, Dunn LB, Dhruva A, et al. Differences in demographic, clinical, and symptom characteristics and quality of life outcomes among oncology patients with different types of pain. Pain. 2016;157:892–900.
   PubMed Web of Science ®Google Scholar
• Brant JM. The global experience of cancer pain. Asian Pac J Cancer Prev. 2010;11(Suppl 1):7–12.
   PubMedGoogle Scholar
• Haumann J, Joosten EA, van den Bueken-van Everdingen MH. Pain prevalence in cancer patients: status quo or opportunities for improvement? Curr Opin Support Palliat Care. 2017;11:99–104.
   PubMed Web of Science ®Google Scholar
• Cancer Research UK. Cancer Statistics for the UK. [cited 2018 January 7]. Available from: www.cancerresearchuk.org/health-professional/cancer-statistics
   Google Scholar
• Glare PA, Davies PS, Finlay E, et al. Pain in cancer survivors. J Clin Oncol. 2014;32:1739–1747.
   PubMed Web of Science ®Google Scholar
• Santini D, Lanzetta G, Dell’Aquila E, et al. ‘Old’ and ‘new’ drugs for the treatment of cancer pain. Expert Opin Pharmacother. 2013;14:425–433.
   PubMed Web of Science ®Google Scholar
• Kaasa S. Is cancer pain control improved by a simple WHO pain analgesic ladder approach combined with tumor-directed treatment? J Clin Oncol. 2016;34:399–400.
   PubMed Web of Science ®Google Scholar
• Greco MT, Roberto A, Corli O, et al. Quality of cancer pain management: an update of a systematic review of undertreatment of patients with cancer. J Clin Oncol. 2014;32:4149–4154.
   PubMed Web of Science ®Google Scholar
• Bennett M, Paice JA, Wallace M. Pain and opioids in cancer care: benefits, risks, and alternatives. Am Soc Clin Oncol Educ Book. 2017;37:705–713.
   PubMedGoogle Scholar
• Moryl N, Dave V, Glare P, et al. Patient-reported outcomes and opioid use by outpatient cancer patients. J Pain. 2017;19(3):278–290. Epub ahead of print.
   PubMedGoogle Scholar
• van den Beuken-van Everdingen M, Hochstenbach L, Joosten E, et al. Update on prevalence of pain in patients with cancer: systematic review and metaanalysis. J Pain Symptom Manage. 2016;51:1070–1090.
   PubMed Web of Science ®Google Scholar
• Office of Cancer Survivorship, National Cancer Institute. Washington, DC: office of Cancer Survivorship, National Cancer Institute; 2012. About Cancer Survivorship Research: Survivorship Definitions, Cancer Survivorship Research. Available from: http://cancercontrol.cancer.gov/ocs/researcher_factsheet.pdf
   Google Scholar
• Centers for Disease Control and Prevention. Cancer survivors: united States, 2007. MMWR Morb Mortal Wkly Rep. 2011;60:269–272.
   PubMedGoogle Scholar
• Manchikanti L, Kaye AM, Knezevic NN, et al. Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: american Society of Interventional Pain Physicians (ASIPP) guidelines. Pain Physician. 2017;20:S3–92.
   PubMed Web of Science ®Google Scholar
• Kaye AD, Jones MR, Kaye AM, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: Part 1. Pain Physician. 2017;20:S93–109.
   PubMed Web of Science ®Google Scholar
• Kaye AD, Jones MR, Kaye AM, et al. Prescription opioid abuse in chronic pain: an updated review of opioid abuse predictors and strategies to curb opioid abuse: part 2. Pain Physician. 2017;20:S111–33.
   PubMed Web of Science ®Google Scholar
• van den Beuken-van Everdingen M, de Rijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18:1437–1449.
   PubMed Web of Science ®Google Scholar
• WHO. Cancer Pain. Relief (ed 2). WHO: Geneva, Switzerland; 1996.
   Google Scholar
• National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Adult Cancer Pain, Volume 2. 2016 . [cited 2018 January 7]. Available from: www.nccn.org
   Google Scholar
• Koyyalagunta D, Bruera E, Aigner C, et al. Risk stratification of opioid misuse among patients with cancer pain using the SOAPP-SF. Pain Med. 2013;14:667–675.
   PubMed Web of Science ®Google Scholar
• Foley KM. The treatment of cancer pain. N Engl J Med. 1985;313:84–95.
   PubMed Web of Science ®Google Scholar
• Koyyalagunta D, Bruera E, Engle MP, et al. Compliance with opioid therapy: distinguishing clinical characteristics and demographics among patients with cancer pain. Pain Med. 2017. Epub ahead of print.
   PubMedGoogle Scholar
• Novy DM, Lam C, Gritz E, et al. Distinguishing features of cancer patients who smoke: pain, symptom burden, and risk for opioid misuse. J Pain. 2012;13:1058–1067.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Abdi S, Atluri S, et al. An update of comprehensive evidence-based guidelines for interventional techniques of chronic spinal pain: part II: guidance and recommendations. Pain Physician. 2013;16:S49–283.
   PubMedGoogle Scholar
• Scott-Warren J, Bhaskar A. Cancer pain management: part II: interventional techniques. Cont Ed Anaesth Crit Care Pain. 2015;15:68–72.
   Google Scholar
• de Courcy JG. Interventional techniques for cancer pain management. Clin Oncol. 2011;23:407–417.
   Web of Science ®Google Scholar
• Bhatnagar S, Gupta M. Evidence-based clinical practice guideline for interventional pain management in cancer pain. Indian J Palliat Care. 2015;21:137–147.
   PubMedGoogle Scholar
• Paley CA, Johnson MI, Tashani OA, et al. Acupuncture for cancer pain in adults. Cochrane Database Syst Rev. 2015;10:CD007753.
   Google Scholar
• Garcia MK, McQuade J, Haddad R, et al. Systematic review of acupuncture in cancer care: a synthesis of the evidence. J Clin Oncol. 2013;31:952–960.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Knezevic NN, Boswell MV, et al. Epidural injections for lumbar radiculopathy and spinal stenosis: a comparative systematic review and meta-analysis. Pain Physician. 2016;19 (3):E365–410.
   PubMed Web of Science ®Google Scholar
• Grider JS, Manchikanti L, Carayannopoulos A, et al. Effectiveness of spinal cord stimulation in chronic spinal pain: a systematic review. Pain Physician. 2016;19:E33–54.
   PubMed Web of Science ®Google Scholar
• Simopoulos TT, Manchikanti L, Gupta S, et al. Systematic review of the diagnostic accuracy and therapeutic effectiveness of sacroiliac joint interventions. Pain Physician. 2015;18:E713–56.
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim JY, Yeo S, et al. Meta-analysis of massage therapy on cancer pain. Integr Cancer Ther. 2015;14:297–304.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Hirsch JA, Falco FJ, et al. Management of lumbar zygapophysial (facet) joint pain. World J Orthop. 2016;7:315–337.
   PubMedGoogle Scholar
• Manchikanti L, Hirsch JA, Kaye AD, et al. Cervical zygapophysial (facet) joint pain: effectiveness of interventional management strategies. Postgrad Med. 2016;128:54–68.
   PubMed Web of Science ®Google Scholar
• Hellm II S, Racz GB, Gerdesmeyer L, et al. Percutaneous and endoscopic adhesiolysis in managing low back and lower extremity pain: a systematic review and meta-analysis. Pain Physician. 2016;19:E245–82.
   PubMed Web of Science ®Google Scholar
• Helm S 2nd, Simopoulos TT, Stojanovic MP, et al. Effectiveness of thermal annular procedures in treating discogenic low back pain. Pain Physician. 2017;20:447–470.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Manchikanti KN, Gharibo CG, et al. Efficacy of percutaneous adhesiolysis in the treatment of lumbar post surgery syndrome. Anesth Pain Med. 2016;6:e26172.
   PubMedGoogle Scholar
• Manchikanti L, Kaye AD, Manchikanti KN, et al. Efficacy of epidural injections in the treatment of lumbar central spinal stenosis: a systematic review. Anesth Pain Med. 2015;5:e23139.
   PubMedGoogle Scholar
• Arcidiacono PG, Calori G, Carrara S, et al. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev. 2011;3:CD007519.
   Google Scholar
• Karmakar MK, Samy W, Li JW, et al. Thoracic paravertebral block and its effects on chronic pain and health-related quality of life after modified radical mastectomy. Reg Anesth Pain Med. 2014;39:289–298.
   PubMed Web of Science ®Google Scholar
• Bruel BM, Burton AW. Intrathecal therapy for cancer-related pain. Pain Med. 2016;17:2404–2421.
   PubMed Web of Science ®Google Scholar
• Pope JE, Deer TR. Intrathecal pharmacology update: novel dosing strategy for intrathecal monotherapy ziconotide on efficacy and sustainability. Neuromodulation. 2015;18:414–420.
   PubMed Web of Science ®Google Scholar
• Hirsch JA, Chandra RV, Pampati V, et al. Analysis of vertebral augmentation practice patterns: a 2016 update. J Neurointer Surg. 2016;8:1299–1304.
   Web of Science ®Google Scholar
• Ong KL, Beall DI, Frohbergh M, et al. Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty “sham” trials? Osteoporos Int. 2018;29(2):375–383. Epub ahead of print.
   Web of Science ®Google Scholar
• Kwekkeboom KL, Cherwin CH, Lee JW, et al. Mind-body treatments for the pain-fatiguesleep disturbance symptom cluster in persons with cancer. J Pain Symptom Manage. 2010;39:126–138.
   PubMed Web of Science ®Google Scholar
• Johannsen M, Farver I, Beck N, et al. The efficacy of psychosocial intervention for pain in breast cancer patients and survivors: a systematic review and meta-analysis. Breast Cancer Res Treat. 2013;138:675–690.
   PubMed Web of Science ®Google Scholar
• Cramer H, Lauche R, Paul A, et al. Hypnosis in breast cancer care: a systematic review of randomized controlled trials. Integr Cancer Ther. 2015;14:5–15.
   PubMed Web of Science ®Google Scholar
• Fong DY, Ho JW, Hui BP, et al. Physical activity for cancer survivors: meta-analysis of randomized controlled trials. Bmj. 2012;344:e70.
   PubMed Web of Science ®Google Scholar
• Wilkie G, Sakr B, Rizack T. Medical marijuana use in oncology: a review. JAMA Oncol. 2016;2:670. Epub ahead of print.
   Web of Science ®Google Scholar
• Koyyalagunta D, Bruera E, Solanki DR, et al. A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Physician. 2012;15:ES39–ES58.
   PubMed Web of Science ®Google Scholar
• Mercadante S. New drugs for pain management in advanced cancer patients. Expert Opin Pharmacother. 2017;18:497–502.
   PubMed Web of Science ®Google Scholar
• Schmidt-Hansen M, Bennett MI, Arnold S, et al. Oxycodone for cancer-related pain. Cochrane Database Syst Rev. 2017;8:CD003870.
   PubMedGoogle Scholar
• Schmidt-Hansen M, Bromham N, Taubert M, et al. Buprenorphine for treating cancer pain. Cochrane Database Syst Rev. 2015;3:CD009596.
   Google Scholar
• Bao YJ, Hou W, Kong XY, et al. Hydromorphone for cancer pain. Cochrane Database Syst Rev. 2016;10:CD011108.
   PubMedGoogle Scholar
• Manchikanti L, Kaye AM, Kaye AD. Current state of opioid therapy and abuse. Curr Pain Headache Rep. 2016;20:34.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Atluri S, Kaye AM, et al. Hydrocodone bitartrate for chronic pain. Drugs Today. 2015;51:415–427.
   PubMed Web of Science ®Google Scholar
• Dowell D, Noonan RK, Houry D. Underlying factors in drug overdose deaths. Jama. 2017;318:2295–2296.
   PubMed Web of Science ®Google Scholar
• Guy GP Jr, Zhang K, Bohm MK, et al. Vital Signs: changes in opioid prescribing in the United States, 2006-2015. MMWR Morb Mortal Wkly Rep. 2017;66:697–704.
   PubMed Web of Science ®Google Scholar
• Singer JA Stop calling it an opioid crisis – it’s a heroin and fentanyl crisis. Cato Institute, 2018 Jan 9. Availablr from: https://www.cato.org/blog/stop-calling-it-opioid-crisis-its-heroin-fentanyl-crisis [62].
   Google Scholar
• Gottlieb S FDA takes important step to stem the tide of opioid misuse and abuse. FDA Voice, 2017 Sept 28. Available from: https://blogs.fda.gov/fdavoice/index.php/2017/09/fda-takes-important-steps-to-stem-the-tide-of-opioid-misuse-and-abuse/
   Google Scholar
• Cicero TJ, Ellis MS, Kasper ZA. Increased use of heroin as an initiating opioid of abuse. Addict Behav. 2017;74:63–66.
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Ellis MS, Kasper ZA. Increases in self-reported fentanyl use among a population entering drug treatment: the need for systematic surveillance of illicitly manufactured opioids. Drug Alcohol Depend. 2017;177:101–103.
   PubMed Web of Science ®Google Scholar
• Kolodny A, Frieden TR. Ten steps the federal government should take now to reverse the opioid addiction epidemic. Jama. 2017;318:1537–1538.
   PubMed Web of Science ®Google Scholar
• Bonnie RJ, Kesselheim AS, Clark DJ. Both urgency and balance needed in addressing opioid epidemic: a report from the national academies of sciences, engineering, and medicine. Jama. 2017;318:423–424.
   PubMed Web of Science ®Google Scholar
• Volkow ND, McLellan AT. Opioid abuse in chronic pain – misconceptions and mitigation strategies. N Engl J Med. 2016;374:1253–1263.
   PubMed Web of Science ®Google Scholar
• Schuchat A, Houry D, Guy GP Jr. New data on opioid use and prescribing in the United States. Jama. 2017;318:425–426.
   PubMed Web of Science ®Google Scholar
• Rutkow L, Vernick JS. Emergency legal authority and the opioid crisis. N Engl J Med. 2017;377:2512–2514.
   PubMed Web of Science ®Google Scholar
• Yazdani S, Abdi S. Brief review: pain management for cancer survivors: challenges and opportunities. Can J Anesth. 2014;61:745–753.
   PubMed Web of Science ®Google Scholar
• Balducci L. Supportive care in elderly cancer patients. Curr Opin Oncol. 2009;21:310–317.
   PubMed Web of Science ®Google Scholar
• Cataldo JK, Paul S, Cooper B, et al. Differences in the symptom experience of older versus younger oncology outpatients: a cross-sectional study. BMC Cancer. 2013;13:6.
   PubMed Web of Science ®Google Scholar
• Dieleman JL, Baral R, Birger M, et al. US spending on personal health care and public health, 1996-2013. Jama. 2016;316:2627–2646.
   PubMed Web of Science ®Google Scholar
• Hoy D, March L, Brooks P, et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73:968–974.
   PubMed Web of Science ®Google Scholar
• Hoy D, March L, Woolf A, et al. The global burden of neck pain: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73:1309–1315.
   PubMed Web of Science ®Google Scholar
• Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
   PubMed Web of Science ®Google Scholar
• Piccirillo JF, Tierney RM, Costas I, et al. Prognostic importance of comorbidity in a hospital-based cancer registry. Jama. 2004;291:2441–2447.
   PubMed Web of Science ®Google Scholar
• Read WL, Tierney RM, Page NC, et al. Differential prognostic impact of comorbidity. J Clin Oncol. 2004;22:3099–3103.
   PubMed Web of Science ®Google Scholar
• Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. 2011;12:725–746.
   PubMed Web of Science ®Google Scholar
• Belfer I, Schreiber KL, Shaffer JR, et al. Persistent postmastectomy pain in breast cancer survivors: analysis of clinical, demographic, and psychosocial factors. J Pain. 2013;14:1185–1195.
   PubMed Web of Science ®Google Scholar
• Miaskowski C, Cooper B, Paul SM, et al. Identification of patient subgroups and risk factors for persistent breast pain following breast cancer surgery. J Pain. 2012;13:1172–1187.
   PubMed Web of Science ®Google Scholar
• Miaskowski C, Paul SM, Cooper B, et al. Identification of patient subgroups and risk factors for persistent arm/shoulder pain following breast cancer surgery. Eur J Oncol Nurs. 2014;18:242–253.
   PubMed Web of Science ®Google Scholar
• Katipamula R, Degnim AC, Hoskin T, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009;27:4082–4088.
   PubMed Web of Science ®Google Scholar
• Fallon MT. Neuropathic pain in cancer. Br J Anaesth. 2013;111:105–111.
   PubMed Web of Science ®Google Scholar
• Levy MH, Chwistek M, Mehta RS. Management of chronic pain in cancer survivors. Cancer J. 2008;14:401–409.
   PubMed Web of Science ®Google Scholar
• Carozzi VA, Canta A, Chiorazzi A, et al. Chemotherapy-induced peripheral neuropathy: what do we know about mechanisms? Neurosci Lett. 2015;596:90–107.
   PubMed Web of Science ®Google Scholar
• Cleeland CS, Farrar JT, Hausheer FH. Assessment of cancer-related neuropathy and neuropathic pain. Oncologist. 2010;15 Suppl 2:13–18.
   PubMed Web of Science ®Google Scholar
• Alles SRA, Smith PA. Etiology and Pharmacology of Neuropathic Pain. Pharmacol Rev. 2018;70(2):315–347.
   PubMed Web of Science ®Google Scholar
• Windebank AJ, Grisold W. Chemotherapy-induced neuropathy. J Peripher Nerv Syst. 2008;13:27–46.
   PubMed Web of Science ®Google Scholar
• King S, Forbes K, Hanks GW, et al. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project. Palliat Med. 2011;25:525–552.
   PubMed Web of Science ®Google Scholar
• Deandrea S, Montanari M, Moja L, et al. Prevalence of undertreatment in cancer pain: a review of published literature. Ann Oncol. 2008;19:1985–1991.
   PubMed Web of Science ®Google Scholar
• Apolone G, Corli O, Caraceni A, et al. Pattern and quality of care of cancer pain management: results from the Cancer Pain Outcome Research Study Group. Br J Cancer. 2009;100:1566–1574.
   PubMed Web of Science ®Google Scholar
• Fisch MJ, Lee JW, Weiss M, et al. Prospective observational study of pain and analgesic prescribing in medical oncology outpatients with breast, colorectal, lung or prostatic cancer. J Clin Oncol. 2012;30:1980–1988.
   PubMed Web of Science ®Google Scholar
• Mitera G, Zeiadin N, Kirou-Mauro A, et al. Retrospective assessment of cancer pain management in an outpatient palliative radiotherapy clinic using the Pain Management Index. J Pain Symptom Manage. 2010;39:259–267.
   PubMed Web of Science ®Google Scholar
• Portenoy RK. Treatment of cancer pain. Lancet. 2011;377:2236–2247.
   PubMed Web of Science ®Google Scholar
• Setiabudy R, Irawan C, Sudoyo AW. Opioid use in cancer pain management in Indonesia: a call for attention. Acta Med Indones. 2015;47:244–250.
   PubMed Web of Science ®Google Scholar
• Banegas MP, Dickerson JF, Kent EE, et al. Exploring barriers to the receipt of necessary medical care among cancer survivors under age 65 years. J Cancer Surviv. 2018;12(1):28-37. Epub ahead of print.
   Web of Science ®Google Scholar
• Mercadante S, Cuomo A. Breakthrough cancer pain: ten commandments. Value Health. 2016;19:531–536.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Singh V, Caraway DL, et al. Breakthrough pain in chronic non-cancer pain: fact, fiction, or abuse. Pain Physician. 2011;14:E103–17.
   PubMed Web of Science ®Google Scholar
• Manchikanti L, Atluri S, Hansen H, et al. Opioids in chronic noncancer pain: have we reached a boiling point yet? Pain Physician. 2014;17:E1–10.
   PubMed Web of Science ®Google Scholar
• Bennett MI, Graham J, Schmidt-Hansen M, et al. Prescribing strong opioids for pain in adult palliative care: summary of NICE guidance. Bmj. 2012;344:e2806.
   PubMedGoogle Scholar
• Schmidt-Hansen M, Bennett MI, Hilgart J. Oxycodone for cancer pain in adult patients. Jama. 2015;314:1282–1283.
   PubMed Web of Science ®Google Scholar
• Moore RA, Derry S, Taylor RS, et al. The costs and consequences of adequately managed chronic non-cancer pain and chronic neuropathic pain. Pain Practice. 2014;14:79–94.
   PubMed Web of Science ®Google Scholar
• Caraceni A, Hanks G, Kaasa S, et al. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol. 2012;13:e58–68.
   PubMed Web of Science ®Google Scholar
• Corli O, Montanari M, Deandrea S, et al. An exploratory analysis on the effectiveness of four strong opioids in patients with cancer pain. Pain Med. 2012;13:897–907.
   PubMed Web of Science ®Google Scholar
• Zecca E, Brunelli C, Bracchi P, et al. Comparison of the tolerability profile of controlled-release oral morphine and oxycodone for cancer pain treatment. Open-Label Randomized Controlled Trial J Pain Symptom Manage. 2016;52:783–794.
   PubMed Web of Science ®Google Scholar
• Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain–united States, 2016. MMWR Recomm Rep. 2016;65:1–49.
   PubMed Web of Science ®Google Scholar
• Piana R ASCO addresses new policies that threaten access to opioids. The ASCO Post, March 25, 2017. [cited 2018 January 7]. Available from: http://www.ascopost.com/issues/march-25-2017/asco-addresses-new-policies-that-threaten-access-to-opioids/
   Google Scholar
• Arthur JA, Haider A, Edwards T, et al. Aberrant opioid use and urine drug testing in outpatient palliative care. J Palliat Med. 2016;19:778–782.
   PubMed Web of Science ®Google Scholar
• Arthur JA, Edwards T, Lu Z, et al. Frequency, predictors, and outcomes of urine drug testing among patients with advanced cancer on chronic opioid therapy at an outpatient supportive care clinic. Cancer. 2016;122:3732–3739.
   PubMed Web of Science ®Google Scholar
• Koyyalagunta D, Burton AW, Toro MP, et al. Opioid abuse in cancer pain: report of two cases and presentation of an algorithm of multidisciplinary care. Pain Physician. 2011;14:E361–71.
   PubMed Web of Science ®Google Scholar
• Childers JW, King LA, Arnold RM. Chronic pain and risk factors for opioid misuse in a palliative care clinic. Am J Hosp Palliat Care. 2015;32:654–659.
   PubMed Web of Science ®Google Scholar
• Barclay JS, Owens JE, Blackhall LJ. Screening for substance abuse risk in cancer patients using the Opioid Risk Tool and urine drug screen. Support Care Cancer. 2014;22:1883–1888.
   PubMed Web of Science ®Google Scholar
• Reyes-Gibby CC, Anderson KO, Todd KH. Risk for opioid misuse among emergency department cancer patients. Acad Emerg Med. 2016;23:151–158.
   PubMedGoogle Scholar
• Baliki MN, Mansour AR, Baria AT, et al. Functional reorganization of the default mode network across chronic pain conditions. PLoS One. 2014;9:e106133.
   PubMed Web of Science ®Google Scholar
• Hemington KS, Wu Q, Kucyi A, et al. Abnormal cross-network functional connectivity in chronic pain and its association with clinical symptoms. Brain Struct Funct. 2016;221:4203–4219.
   PubMed Web of Science ®Google Scholar
• Loggia ML, Kim J, Gollub RL, et al. Default mode network connectivity encodes clinical pain: an arterial spin labeling study. Pain. 2013;154:24–33.
   PubMed Web of Science ®Google Scholar
• Corder G, Doolen S, Donahue RR, et al. Constitutive mu-opioid receptor activity leads to long-term endogenous analgesia and dependence. Science. 2013;341:1394–1399.
   PubMed Web of Science ®Google Scholar
• Vozoris NT, O’Donnell DE, Bell C, et al. Incident opioid use is associated with risk of respiratory harm in non-palliative COPD. Eur Respir J. 2017;49:3.
   Google Scholar
• Vozoris NT, O’Donnell DE, Bell CM, et al. Opioids in COPD: a cause of death or a marker of illness severity? Eur Respir J. 2016;48:1521–1522.
   PubMedGoogle Scholar
• Vozoris NT, Wang X, Fischer HD, et al. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J. 2016;48:683–693.
   PubMed Web of Science ®Google Scholar
• Chou R, Fanciullo GJ, Fine PG, et al. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain. 2009;10:131–146.
   PubMed Web of Science ®Google Scholar
• CGS ination (LCD) for Controlled Substance Monitoring and Drugs of Abuse Testing (L36029). Revision Effective Date: 10/ 01/2017.
   Google Scholar
• Atluri SL, Akbik H, Sudarshan G. Prevention of opioid abuse in chronic noncancer pain: an algorithmic, evidence-based approach. Pain Physician. 2012;15:ES177–189.
   PubMed Web of Science ®Google Scholar
• Agency Medical Directors Group. Interagency Guidelines on Opioid Dosing for Chronic Non-cancer Pain: an educational aid to improve care and safety with opioid therapy. 2010 Update. [cited 2018 January 7]. Available from: www.agencymeddirectors.wa.gov/Files/OpioidGdline.pdf
   Google Scholar
• Chou R, Fanciullo GJ, Fine PG, et al. American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–130.
   PubMed Web of Science ®Google Scholar
• National Opioids Use Guideline Group (NOUGG). Canadian guidelines for safe and effective use of opioids for chronic non-cancer pain, Recommendations for Practice, Version 5.6. Apr 30, 2010. Available from: http://nationalpaincentre.mcmaster.ca/documents/opioid_guideline_part_b_v5_6.pdf
   Google Scholar
• Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2 – guidance. Pain Physician. 2012;15:S67–116.
   PubMed Web of Science ®Google Scholar
• Kentucky Board of Medical Licensure (KBML). Guidelines for the Use of Controlled Substances in Pain Treatment. [cited 2018 January 7]. Available from: http://media.kentucky.com/smedia/2008/08/01/19/UseofCSsinPainTreatment.source.prod_affiliate.79.pdf
   Google Scholar
• Colson J, Helm S, Silver S. Office-based opioid dependence treatment. Pain Physician. 2012;15:ES231–6.
   PubMed Web of Science ®Google Scholar